Cite
NIH Consensus Development Conference Statement: Inhaled Nitric-Oxide Therapy for Premature Infants.
MLA
Cole, F.Sessions, et al. “NIH Consensus Development Conference Statement: Inhaled Nitric-Oxide Therapy for Premature Infants.” Pediatrics, vol. 127, no. 2, Feb. 2011, pp. 363–69. EBSCOhost, https://doi.org/10.1542/peds.2010-3507.
APA
Cole, F. S., Alleyne, C., Barks, J. D. E., Boyle, R. J., Carroll, J. L., Dokken, D., Edwards, W. H., Georgieff, M., Gregory, K., Johnston, M. V., Kramer, M., Mitchell, C., Neu, J., Pursley, D. M., Robinson, W. M., & Rowitch, D. H. (2011). NIH Consensus Development Conference Statement: Inhaled Nitric-Oxide Therapy for Premature Infants. Pediatrics, 127(2), 363–369. https://doi.org/10.1542/peds.2010-3507
Chicago
Cole, F. Sessions, Claudia Alleyne, John D. E. Barks, Robert J. Boyle, John L. Carroll, Deborah Dokken, William H. Edwards, et al. 2011. “NIH Consensus Development Conference Statement: Inhaled Nitric-Oxide Therapy for Premature Infants.” Pediatrics 127 (2): 363–69. doi:10.1542/peds.2010-3507.